Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
E. Cecon, D. Fernandois, N. Renault, C. F. F. Coelho, J. Wenzel, C. Bedart, C. Izabelle, S. Gallet, S. Le Poder, B. Klonjkowski, M. Schwaninger, V. PREVOT, J. Dam, R. Jockers
This study shows melatonin and its derivatives prevent SARS-CoV-2 brain entry and reduce cerebral damage in a mouse model.
bioRxiv · Dec 30, 2021Pharmacology & Toxicology